{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T15:46:57Z","timestamp":1776786417446,"version":"3.51.2"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ningbo Medical Science and Technology Plan Project","award":["No.2020Y46"],"award-info":[{"award-number":["No.2020Y46"]}]},{"name":"Ningbo Yinzhou District Science and Technology Project","award":["No.yinke2020-70"],"award-info":[{"award-number":["No.yinke2020-70"]}]},{"name":"Zhejiang Medicine and Health Science and Technology Project","award":["No.2018KY748"],"award-info":[{"award-number":["No.2018KY748"]}]},{"DOI":"10.13039\/100007834","name":"Natural Science Foundation of Ningbo","doi-asserted-by":"publisher","award":["No.2019A610352"],"award-info":[{"award-number":["No.2019A610352"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ningbo Science and Technology Project","award":["Nos.2019C50085"],"award-info":[{"award-number":["Nos.2019C50085"]}]},{"name":"Ningbo major science and technology task project","award":["No.2021Z054"],"award-info":[{"award-number":["No.2021Z054"]}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["No.LY20C090001"],"award-info":[{"award-number":["No.LY20C090001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000887"],"award-info":[{"award-number":["82000887"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To report a very rare acute cystoid macular oedema following ganciclovir injection in patients receiving allogeneic haematopoietic stem cell transplantation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 44-year-old male patient experienced vision loss in his left eye eight months after allogeneic stem cell transplantation. Ophthalmologic examination showed posterior retinopathy with retinal haemorrhage, a yellow necrotic border, and a vascular white sheath involved in the superior temporal retina but not the posterior pole. Cytomegalovirus DNA results in both plasma and ocular fluid were positive. All tests combined with the patient\u2019s medical history suggested that his ocular disease was cytomegalovirus retinitis. Consequently, he received a weekly ganciclovir vitreous injection. The disease was visibly controlled, and the fundus condition improved after the first three treatments. However, the patient had severe vision loss in his left eye and acute cystic oedema in the macula, while the original lesion was stable two hours after the fourth treatment. The macular oedema subsided significantly on the first day. Over the next week, daily OCT findings indicated that the patient's macular oedema gradually subsided and resolved completely by the second week, and his left eye vision partially improved.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Macular oedema may occur in patients with cytomegalovirus retinitis, but it rarely occurs during treatment. In this case, the patient's macular oedema appeared and resolved quickly. Macular oedema in patients with cytomegalovirus retinitis receiving vitreous cavity injections of ganciclovir needs to be further studied and discussed.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-022-02500-0","type":"journal-article","created":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T07:05:38Z","timestamp":1656399938000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["CMV retinitis and subsequent acute cystoid macular oedema after treatment with vitreous ganciclovir injection: a case report"],"prefix":"10.1186","volume":"22","author":[{"given":"Mengyun","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hengqian","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinkang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juntao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,28]]},"reference":[{"issue":"2","key":"2500_CR1","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/eye.2011.327","volume":"26","author":"A Carmichael","year":"2012","unstructured":"Carmichael A. Cytomegalovirus and the eye. Eye (Lond). 2012;26(2):237\u201340.","journal-title":"Eye (Lond)"},{"issue":"3","key":"2500_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.tjo.2015.07.004","volume":"6","author":"EJ Huang","year":"2016","unstructured":"Huang EJ, et al. Rapid regression of cystoid macular edema associated with cytomegalovirus retinitis in adult acute myeloid leukemia by intravitreal methotrexate combined with oral valganciclovir: a case report with comparison of binocular outcome. Taiwan J Ophthalmol. 2016;6(3):145\u20139.","journal-title":"Taiwan J Ophthalmol"},{"issue":"4","key":"2500_CR3","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1128\/JCM.36.4.1113-1116.1998","volume":"36","author":"G Gerna","year":"1998","unstructured":"Gerna G, et al. Rising levels of human cytomegalovirus (HCMV) antigenemia during initial antiviral treatment of solid-organ transplant recipients with primary HCMV infection. J Clin Microbiol. 1998;36(4):1113\u20136.","journal-title":"J Clin Microbiol"},{"issue":"9","key":"2500_CR4","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1182\/blood.V75.9.1888.1888","volume":"75","author":"P Reusser","year":"1990","unstructured":"Reusser P, et al. Cytomegalovirus infection after autologous bone marrow transplantation: occurrence of cytomegalovirus disease and effect on engraftment. Blood. 1990;75(9):1888\u201394.","journal-title":"Blood"},{"issue":"3","key":"2500_CR5","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1086\/517301","volume":"176","author":"JA Zaia","year":"1997","unstructured":"Zaia JA, et al. Late cytomegalovirus disease in marrow transplantation is predicted by virus load in plasma. J Infect Dis. 1997;176(3):782\u20135.","journal-title":"J Infect Dis"},{"issue":"12","key":"2500_CR6","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1001\/archopht.1986.01050240062041","volume":"104","author":"DJ D'Amico","year":"1986","unstructured":"D\u2019Amico DJ, et al. Ophthalmoscopic and histologic findings in cytomegalovirus retinitis treated with BW-B759U. Arch Ophthalmol. 1986;104(12):1788\u201393.","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"2500_CR7","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0736-4679(84)90331-7","volume":"2","author":"D Seger","year":"1984","unstructured":"Seger D. Acquired immune deficiency syndrome. J Emerg Med. 1984;2(2):117\u201328.","journal-title":"J Emerg Med"},{"issue":"4","key":"2500_CR8","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1089\/jop.2016.0140","volume":"33","author":"AD Port","year":"2017","unstructured":"Port AD, et al. Cytomegalovirus retinitis: a Review. J Ocul Pharmacol Ther. 2017;33(4):224\u201334.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"7","key":"2500_CR9","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/eye.2013.107","volume":"27","author":"KG Falavarjani","year":"2013","unstructured":"Falavarjani KG, Nguyen QD. Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature. Eye (Lond). 2013;27(7):787\u201394.","journal-title":"Eye (Lond)"},{"issue":"7","key":"2500_CR10","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/j.1755-3768.2009.01535.x","volume":"88","author":"AM Mansour","year":"2010","unstructured":"Mansour AM, et al. Retinal vascular events after intravitreal bevacizumab. Acta Ophthalmol. 2010;88(7):730\u20135.","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"2500_CR11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1755-3768.2008.01406.x","volume":"88","author":"T von Hanno","year":"2010","unstructured":"von Hanno T, Kinge B, Fossen K. Retinal artery occlusion following intravitreal anti-VEGF therapy. Acta Ophthalmol. 2010;88(2):263\u20136.","journal-title":"Acta Ophthalmol"},{"key":"2500_CR12","doi-asserted-by":"publisher","unstructured":"Furino C, Boscia F, Cardascia N, Alessio G, Sborgia C. Hemorrhagic macular infarction after intravitreal bevacizumab for central retinal vein occlusion. Ophthalmic Surg Lasers Imaging. 2010. p. 1-2. https:\/\/doi.org\/10.3928\/15428877-20100215-57. Epub ahead of print.","DOI":"10.3928\/15428877-20100215-57"},{"issue":"12","key":"2500_CR13","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s00417-009-1184-5","volume":"247","author":"M Ganssauge","year":"2009","unstructured":"Ganssauge M, et al. Non-arteritic anterior ischemic optic neuropathy (NA-AION) after intravitreal injection of bevacizumab (Avastin) for treatment of angoid streaks in pseudoxanthoma elasticum. Graefes Arch Clin Exp Ophthalmol. 2009;247(12):1707\u201310.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"2500_CR14","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/WNO.0b013e3181a58fd1","volume":"29","author":"H Hosseini","year":"2009","unstructured":"Hosseini H, Razeghinejad MR. Anterior ischemic optic neuropathy after intravitreal injection of bevacizumab. J Neuroophthalmol. 2009;29(2):160\u20131.","journal-title":"J Neuroophthalmol"},{"issue":"2","key":"2500_CR15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000235726","volume":"224","author":"ZL Huang","year":"2010","unstructured":"Huang ZL, et al. Acute vision loss after intravitreal injection of bevacizumab (avastin) associated with ocular ischemic syndrome. Ophthalmologica. 2010;224(2):86\u20139.","journal-title":"Ophthalmologica"},{"issue":"12","key":"2500_CR16","doi-asserted-by":"publisher","first-page":"4179","DOI":"10.1128\/JCM.05464-11","volume":"49","author":"SY Park","year":"2011","unstructured":"Park SY, et al. Paradoxical rising cytomegalovirus antigenemia during preemptive ganciclovir therapy in hematopoietic stem cell transplant recipients: incidence, risk factors, and clinical outcomes. J Clin Microbiol. 2011;49(12):4179\u201384.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"2500_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/M13-2729","volume":"162","author":"M Boeckh","year":"2015","unstructured":"Boeckh M, et al. Valganciclovir for the prevention of complications of late cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a randomized trial. Ann Intern Med. 2015;162(1):1\u201310.","journal-title":"Ann Intern Med"},{"key":"2500_CR18","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.3390\/microorganisms9061114","volume":"9","author":"HJ Kwon","year":"2021","unstructured":"Kwon HJ, et al. Clinical characteristics associated with the development of cystoid macular edema in patients with cytomegalovirus retinitis. Microorganisms. 2021;9:1114.","journal-title":"Microorganisms"},{"issue":"4","key":"2500_CR19","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S0161-6420(96)30646-5","volume":"103","author":"AM Maguire","year":"1996","unstructured":"Maguire AM, Nichols CW, Crooks GW. Visual loss in cytomegalovirus retinitis caused by cystoid macular edema in patients without the acquired immune deficiency syndrome. Ophthalmology. 1996;103(4):601\u20135.","journal-title":"Ophthalmology"},{"issue":"22","key":"2500_CR20","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1056\/NEJMcp1003934","volume":"363","author":"TY Wong","year":"2010","unstructured":"Wong TY, Scott IU. Clinical practice retinal-vein occlusion. N Engl J Med. 2010;363(22):2135\u201344.","journal-title":"N Engl J Med"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-022-02500-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-022-02500-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-022-02500-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T07:09:04Z","timestamp":1656400144000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-022-02500-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,28]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2500"],"URL":"https:\/\/doi.org\/10.1186\/s12886-022-02500-0","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,28]]},"assertion":[{"value":"3 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from patient to publish their clinical data and images. A copy of the informed consent form is available for review by the journal editor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All the authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"284"}}